OTC Interactionsss Flashcards
(30 cards)
Cetirizine
All anti histamine medication and MAOIs
Significantly increases antimuscarinics S/E
Loratadine 10mg
ALL antihistamines, other antimuscarinics
Increases antimuscarinics side effects
Chlorphenamine 4mg
Antidepressants, anxiolytics- benzos and hypnotism opioid analgesics, alcohol
Increased CNS depression
Fexofenadine 120mg
Apple and orange juice
Decreases exposure to fexofenadine
Pseudoephedrine/Phenylepherine,Xylometazoline, Oxymetazoline
MAOI
Hypertensive crisis, avoid decongestants for at least 2 weeks after stopping MAOIs
Dextromorphan
Antidepressants, Anxiolytics - benzos and hypnotics, opioids, alcohol, Z drugs
Increased CNS Depression
Chloramphemicol
Sulphonylureas - Enhances effect of S
Tacrolimus- Enhances conc of T
Warfarin - moderate - Potentially increases anticoagulant effect
Paracetamol
Alcohol - heavy drinking - increased liver damage
Flucloxacillin - High anion gap metabolic caution
Warfarin - moderate effect, Phenadione - severe effect = Increases INR
Ibuprofen
Ace/ARB - Hyperkalaemia and renal damage
SSRI/SNRI- Hyperkalemia and renal damage
Baclofen, methotrexate, lithium - reduced excretion of these drugs so increases toxicity
Quinolones - Increased seizures
Thiazides - Increased nephrotoxicity
Co codamolllll
Antidepressants, anxiolytics, hypnotics, opioid analgesics, alcohol,z drugs - Increased CNS depression
Clozapine - Intestinal Obstruction
MAOi - Possible CNS excitation or depression - hypertension or hypotension
Sumatriptan
MAOI- Risk of CNS toxicity when MAOIs given with sumatriptan - avoid sumatriptan for 2 weeks after MAOIs
Serotonin syndrome - Low/moderate risk
Ergotamine - Vasocnstriction - don’t use with 24hrs of E
SSRI, Tapentadol - Serotonin syndrome
Anti- emetic MIGRANES
Prochlorperazine - Antidepressants, anxiolytics, hypnotics, alcohol, z drugs = Increased risk of CNS depression
Anti- hypertensives/phosphodisterase type 5 inhibitors - Can increase hypotension risk
Lithium - Neurotoxicity
Anti- emetics Travel sick
Cinnarizine, Promethaizne, Hyoscine - Antidepressants, anxiolytics, opioids, alcohol, z drugs
Hyoscine - all the above + TCAs and neuroleptics
= Increased antimuscarinics side effects
ALL increase CNS depression
Mebendazole
Cimetidine = Increased mebendazole concentrartion
Cystitis treatment - Potassium Citrate
Arb/ace, potassium sparring diuretics, spirnolactone or potassium supplements
Causes hyper kalameia
EHCCCCCC
Levonorgestrel and Ella one = Carbamazepine, Fosphenytoin,oxcarbazepine, phenobarbital, St John’s wart, rifampicin , Rifabutin
Decreased clinical efficacy of EHC
Fluconazole
- Anticoagulants - INR increased
Citalopram, escitalopram , amiodarone, lithium, Macrolides, antipsychotics, methadone, quinolones, ondansetron = QT prolongation - Torsades De pointes - Thiazide an loop diuretics - causes HYPOOOOO - torsade de pointes
Clopidogrel - cyp3a4 which reduces anti platelet effect
Ciclosporin, rifampicin, phenytoin, tacrolimus - increases plasma conc
Clotrimazole Pessary
No drug interactions but can impact condoms and diaphragm - Damage = decreases contraceptive effectiveness
Period Treatment - Hyoscine Butylbromide = 10mg
Cloazapine- severe increase risk of intestinal obstruction
TCAs, antihistamines, antipsychotics = increased antimuscarinics side effects
Naproxen 250mg
Ace/ARB - Hyperkalaemia and renal damage and renal damage
SSRI/SNRI, anticoagulant - antiplatelets, steroids - increased bleeding
Baclofen/methotrexate/lithium = Reduce the excretion of these drugs - increased risk of toxicity
Quinolones - Increased risk of seizures
Thiazides - Increased risk of nephrotoxicity
Heavy periods - Tranexamic acid
Combined oral contraceptives, cytotoxic medicines, Tamoxifen = Increased risk of thrombotic events
Dyspepsia Treatment - Omeprazole and esoemprazole
Clopidogrel/ Citalopram and ecitalopram = Reduced antiplatelet effect and increased exposure of Citalopram and ecitalopram
ALL PPIS
Methotrexate - reduces clearance - increased risk of toxicity
Some protease inhibitors - PPi decrease the exposure to Atazanavir - Tipranavir decreases exposure to PPi